Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Oxidative stress contributes to hair graying and loss as we age.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

BLIMP1 is essential for skin maintenance but not for defining sebaceous gland progenitors.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Eccrine sweat gland's clear cells likely cause excessive sweating in hyperhidrosis.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.